Thursday, September 23, 2010

BWI: Unichem Laboratories Receives CEP for Alfuzosin Hydrochloride

Press release from Business Wire India
Source: Unichem Laboratories Limited
Thursday, September 23, 2010 12:27 PM IST (06:57 AM GMT)
Editors: General: Consumer interest; Business: Advertising, PR & marketing, Business services, Chemicals, Financial Analyst, Healthcare, biotechnology & pharmaceutical, Retailers, Stock exchanges; Healthcare
--------------------------------------------------
Unichem Laboratories Receives CEP for Alfuzosin Hydrochloride


Mumbai, Maharashtra, India, Thursday, September 23, 2010 -- (Business Wire India) -- Unichem Laboratories Limited has been granted Certificate of suitability to European Pharmacopeia (CEP) by European Directorate for the Quality of Medicines and Healthcare (EDQM) for Alfuzosin Hydrochloride.

The European Directorate for the Quality of Medicines & HealthCare is a Directorate of the Council of Europe located in Strasbourg. EDQM issues COS for APIs manufacturers to assure the APIs quality imported to EU. EDQM establishes and provides users with official standards for the manufacture and quality control of medicines applicable in all the signatory states of the Convention for the elaboration of a European Pharmacopoeia. It is responsible for setting up privileged collaboration with observer states at the European Pharmacopoeia Commission, and organizing a network of Official Medicines Control Laboratories to collaborate and share expertise.

About Unichem Laboratories Limited

Unichem Laboratories Limited is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world. In India, the company is a leader in niche therapy areas of cardiology, neurology, and orthopedics and anti-infectives. The company has strong skills in product development, process chemistry and manufacturing of complex API as well as dosage forms.

More information about the company can be found at www.unichemlabs.com



CONTACT DETAILS
Mr. M Gundu Rao, Unichem Laboratories Limited, +91 9820228944 +91 (22) 66888380, gundurao@unichemlabs.com
Mr. Rakesh Parikh, Unichem Laboratories Limited, +91 9892925555 +91 (22) 66888414, rparikh@unichemlabs.com
Mr. K Subharaman, Unichem Laboratories Limited, +91 9833031121 +91 (22) 66888404, subharamank@unichemlabs.com

KEYWORDS
CONSUMER, MARKETING, BUSINESS SERVICES, CHEMICALS, Financial Analyst, HEALTHCARE, RETAIL, STOCK EXCHANGES, HEALTHCARE

If you wish to change your Business Wire India selection please click on this link http://www.businesswireindia.com/media/news.asp and use your personal username and password to login.

Submit your press release at http://www.businesswireindia.com

No comments:

Post a Comment